Home
Marksans Pharma Ltd Board of Directors
Board of Directors at Marksans Pharma Ltd
Abhinna Mohanty
Non-Exec. & Independent Dir.
Digant Parikh
Non-Exec. & Independent Dir.
Harshavardhan Panigrahi
Company Sec. & Compli. Officer
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole-time Director
Key Highlights
- Mark Saldanha continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
- Harshavardhan Panigrahi continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
- Seetharama Raju Buddharaju continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
- Sandra Saldanha continues to serve as the Whole-time Director in 2024, maintaining the same position as in the previous year.
- Digant Mahesh Parikh continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
Marksans Pharma Ltd
NSE: MARKSANS
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 21 Feb 2025 | 226.1 |
| 20 Feb 2025 | 232.4 |
| 19 Feb 2025 | 227.9 |
| 18 Feb 2025 | 241.05 |
| 17 Feb 2025 | 238.45 |
| 14 Feb 2025 | 230.6 |
| 13 Feb 2025 | 249.5 |
| 12 Feb 2025 | 253.8 |
| 11 Feb 2025 | 251.45 |
| 10 Feb 2025 | 267.4 |
Company Fundamentals for Marksans Pharma Ltd
Market Cap
10,246 Cr
EPS
8.1
P/E Ratio (TTM)
27.8
P/B Ratio (TTM)
4.5
Day’s High
236.4
Day’s Low
224.5
DTE
0.1
ROE
15.2
52 Week High
358.5
52 Week Low
126.05
ROCE
19.0
Market Price of Marksans Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Marksans Pharma Ltd News Hub
Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz
Read more
21 Aug 24
Marksans Pharma gets EIR from USFDA for Goa facility
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
20 Aug 24
Marksans Pharma's Verna unit successfully completes USFDA inspection
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its
Read more
20 Aug 24
Marksans Pharma to convene AGM
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se
Read more
20 Aug 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Marksans Pharma Ltd
How are members of Marksans Pharma Ltd Board of Directors selected?
Members of the Marksans Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Marksans Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Marksans Pharma Ltd Board of Directors?
Shareholders can interact with the Marksans Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Marksans Pharma Ltd Board of Directors meet?
The Marksans Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Marksans Pharma Ltd Board of Directors?
The Marksans Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Marksans Pharma Ltd?
The current Board of Directors at Marksans Pharma Ltd includes Mark Saldanha( Chairman & Managing Director) ,Harshavardhan Panigrahi( Company Sec. & Compli. Officer) ,Seetharama Raju Buddharaju( Non-Exec. & Independent Dir.) ,Sandra Saldanha( Whole-time Director) ,Digant Mahesh Parikh( Non-Exec. & Independent Dir.) . The full list can be found on Marksans Pharma Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
